GLP-1 Side Effects: What to Expect & How to Manage Them

If you're starting a GLP-1 medication like semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro), side effects are probably your biggest concern — and that's completely reasonable. The clinical trials don't sugarcoat it: the majority of patients experience at least one side effect, particularly during the first few months.

But here's what the data also shows: most GLP-1 side effects are gastrointestinal, mild to moderate in severity, and temporary. In the STEP 1 trial, roughly 80% of GI side effects resolved within 4-8 weeks as patients adjusted to each dose level. Only about 7% of participants discontinued semaglutide due to adverse events — meaning the vast majority found the side effects manageable enough to continue treatment.

This guide breaks down every common (and uncommon) GLP-1 side effect, what the clinical evidence says about each one, and practical strategies to manage them. Whether you're about to start your first month on a GLP-1 or you're currently struggling with nausea at a new dose, this is the resource we wish every patient had on day one.

Common GLP-1 Side Effects: What the Clinical Trials Show

The most comprehensive side effect data comes from the STEP trials (semaglutide) and SURMOUNT trials (tirzepatide), which enrolled thousands of participants. Here's what the Wegovy prescribing information and Zepbound prescribing information report for the most common side effects:

A few patterns jump out from this data. First, semaglutide generally has higher rates of nausea and vomiting than tirzepatide — the head-to-head SURMOUNT-5 trial confirmed this, showing a lower GI-related discontinuation rate for tirzepatide (2.7%) compared to semaglutide (5.6%). Second, virtually all of these are GI-related — your digestive system is the primary battleground. Third, constipation and diarrhea can both occur, sometimes alternating, which can be confusing.

Critically, 98.1% of GI side effects in the STEP trials were classified as mild or moderate. Only 4.1% of semaglutide patients reported severe GI reactions. Side effects tend to peak during each dose escalation step and then fade as your body adjusts — which is exactly why these medications use a gradual titration schedule over 16-20 weeks.

Managing Nausea: The Most Common Semaglutide Side Effect

Nausea is the side effect that dominates the conversation around semaglutide and tirzepatide, and for good reason — it affects nearly half of semaglutide users. The good news: it's also the most manageable side effect if you approach it strategically. Most patients report that nausea is worst during the first 2-4 days after a dose increase and then gradually subsides.

Here are the evidence-based strategies that patients and providers consistently report as effective:

• •Follow the titration schedule exactly — This is the single most important factor. Both semaglutide and tirzepatide have specific dose-escalation schedules (starting at 0.25mg and increasing every 4 weeks for semaglutide). Skipping ahead or increasing too quickly dramatically worsens nausea. If your provider suggests staying at a lower dose longer, listen to them.
• •Eat smaller, more frequent meals — Instead of three large meals, try 5-6 smaller portions throughout the day. Large meals overwhelm your now-slower digestive system and trigger nausea. Think "grazing" rather than "feasting."
• •Avoid high-fat and greasy foods — Fat takes longer to digest, and since GLP-1s already slow gastric emptying, fatty meals can sit in your stomach far too long. Lean proteins, whole grains, fruits, and vegetables are generally better tolerated. For a detailed food guide, see our article on foods to avoid on GLP-1 medications.
• •Ginger is evidence-backed — Ginger has legitimate antiemetic properties supported by clinical research. Ginger tea, ginger chews, or ginger capsules (250mg, 4x daily) can help. Many patients swear by ginger candies during the first few days after each injection.
• •Time your injection strategically — Many patients inject in the evening or before bed, so the peak nausea window (6-12 hours post-injection) happens while they're sleeping. Others prefer injecting after a light meal rather than on an empty stomach. Experiment to find your best timing.
• •Stay hydrated — Dehydration worsens nausea. Sip water throughout the day. Some patients find carbonated water or water with lemon easier to tolerate than flat water when nauseated.
• •Avoid lying flat after eating — Sit upright or take a gentle walk after meals. This helps gravity assist your digestion and reduces the feeling of food sitting like a brick in your stomach.

GI Side Effects: Constipation, Diarrhea, and Abdominal Pain

Beyond nausea, the full spectrum of GI side effects can feel like a rollercoaster. Because GLP-1 medications fundamentally change how your digestive system operates — slowing gastric emptying and altering gut motility — your bowel habits will likely change, at least temporarily.

Constipation affects about 24% of semaglutide users and 17-21% of tirzepatide users. Slower gastric emptying means slower transit through your entire GI tract, which leads to harder, less frequent stools. Management strategies include:

• •Increase fiber intake gradually — Add more vegetables, fruits, beans, and whole grains. But increase slowly — dumping too much fiber into an already-slow digestive system can make things worse.
• •Drink significantly more water — Aim for at least 64 oz (2 liters) daily. Dehydration is a major constipation driver, and reduced food intake means you're getting less water from food too.
• •Consider a fiber supplement — Psyllium husk (Metamucil) or methylcellulose (Citrucel) can help bulk stool and promote regularity. Start with half the recommended dose.
• •Magnesium citrate — A natural osmotic laxative that's gentle and effective. Many GLP-1 patients take 200-400mg of magnesium citrate at bedtime. As a bonus, magnesium also helps with sleep and muscle cramps.
• •Move your body — Even a 20-minute daily walk stimulates gut motility. Regular physical activity is one of the most effective natural remedies for constipation.

Diarrhea affects about 30% of semaglutide users and 18-25% of tirzepatide users. It's often worst during the first week at each new dose and typically resolves without intervention. To manage it:

• •Stay hydrated with electrolytes — Diarrhea depletes both water and electrolytes. Use an oral rehydration solution or add electrolyte packets to your water.
• •Avoid artificial sweeteners — Sugar alcohols like sorbitol and erythritol can worsen diarrhea. Check labels on "sugar-free" and "diet" products.
• •Reduce dairy temporarily — Some patients develop temporary lactose sensitivity while on GLP-1 medications. If diarrhea is persistent, try eliminating dairy for a week to see if it helps.
• •The BRAT diet — Bananas, rice, applesauce, and toast can help firm things up during acute episodes.

Abdominal pain (affecting roughly 20% on semaglutide) usually presents as mild cramping or discomfort, particularly after meals. Eating slowly, chewing thoroughly, and avoiding carbonated beverages during meals can help. Pain that is sharp, persistent, or localized to the upper right or upper middle abdomen should be evaluated promptly — it could indicate gallbladder or pancreatic issues (more on those below).

Less Common but Important: Hair Loss, Ozempic Face, and Muscle Loss

These side effects get enormous attention on social media but are often misunderstood. They're less about the medication itself and more about the rapid weight loss it produces.

Hair loss (telogen effluvium) — In the STEP 1 trial, about 3% of semaglutide patients reported hair loss compared to 1% on placebo. This is telogen effluvium — a temporary shedding condition triggered by significant physiological stress, including rapid weight loss. It typically starts 2-4 months after significant weight loss begins, peaks at 6 months, and resolves on its own within 6-12 months as your body adjusts to its new weight. It happens with bariatric surgery at similar rates. Strategies that may help:

• •Ensure adequate protein intake — Aim for at least 60-80g of protein daily. Protein deficiency — common when appetite is dramatically reduced — worsens hair shedding.
• •Take a biotin supplement — 2,500-5,000 mcg daily is a common recommendation, though clinical evidence specifically for GLP-1-related hair loss is limited.
• •Check iron, vitamin D, and zinc levels — Deficiencies in these nutrients contribute to hair loss independently and are more common when eating less.
• •Don't panic — Telogen effluvium is self-limiting. The hair follicles are not damaged; they're just temporarily in a resting phase. New growth will follow.

Ozempic face — This widely-discussed phenomenon refers to facial volume loss that can make patients look gaunt or aged after significant weight loss. It's not a pharmacological side effect of GLP-1 medications — it's a consequence of losing facial fat quickly. It's more noticeable in patients over 40 (who have less skin elasticity) and those who lose large amounts of weight rapidly. Dermal fillers can address this cosmetically, but the best prevention is a moderate pace of weight loss and maintaining adequate nutrition.

Muscle loss (lean mass reduction) — This is arguably the most clinically significant concern. The STEP 1 trial data showed that approximately 39% of weight lost on semaglutide was lean mass (including muscle), compared to about 25% lean mass loss typically seen with diet alone. The SURMOUNT-1 trial showed similar patterns with tirzepatide. To preserve muscle mass:

• •Resistance training 2-3x per week — This is the most evidence-supported strategy. Strength training sends a powerful signal to your body to preserve muscle even during caloric deficit.
• •High protein intake — Target 1.0-1.2g of protein per kilogram of body weight daily. Prioritize protein at every meal and consider a protein supplement if appetite suppression makes it hard to eat enough.
• •Don't skip meals entirely — While appetite suppression is the point, eating nothing puts you in extreme catabolism. Aim for at least 1,200 calories daily with adequate protein, even on days when your appetite is very low.

Rare but Serious GLP-1 Side Effects: Know the Warning Signs

While the vast majority of GLP-1 side effects are GI-related and temporary, there are rare but serious risks that every patient should understand. These are well-documented in the FDA prescribing information and clinical trial data.

Pancreatitis — Acute pancreatitis has been reported in patients taking GLP-1 medications, though the absolute risk is low. In the STEP trials, the incidence was roughly 0.2% (similar to many other medications). Symptoms include severe, persistent upper abdominal pain that may radiate to the back, often accompanied by nausea and vomiting. This pain is distinctly different from the mild GI discomfort that's common with GLP-1s — it's sharp, intense, and doesn't resolve with typical remedies. If you experience this, stop your medication and seek emergency medical care. Risk factors include a history of pancreatitis, gallstones, and heavy alcohol use.

Gallbladder problems — Rapid weight loss (from any cause, including GLP-1s) increases the risk of gallstones and cholecystitis (gallbladder inflammation). In the STEP trials, cholelithiasis occurred in about 1.6% of semaglutide patients vs. 0.7% on placebo. Symptoms include sudden, intense pain in the upper right abdomen, pain between the shoulder blades, nausea, and vomiting — particularly after fatty meals. The Zepbound prescribing information notes similar gallbladder-related events. If you have a history of gallstones, discuss this risk with your provider before starting treatment.

Kidney injury — Dehydration from persistent nausea, vomiting, or diarrhea can lead to acute kidney injury, particularly in patients with pre-existing kidney disease. The prescribing information for both semaglutide and tirzepatide warns about this. The prevention is straightforward: stay aggressively hydrated, especially during dose escalation periods. If you notice dark urine, significantly decreased urination, or swelling in your legs and feet, contact your provider.

Hypoglycemia — GLP-1 medications alone rarely cause dangerously low blood sugar because their insulin-stimulating effect is glucose-dependent. However, patients taking GLP-1s alongside insulin or sulfonylureas (for diabetes) are at elevated risk. Symptoms include shakiness, sweating, confusion, rapid heartbeat, and dizziness. If you're on combination diabetes therapy, work with your provider to adjust doses appropriately.

Semaglutide vs Tirzepatide: Side Effect Comparison

One of the most common questions we hear is whether semaglutide or tirzepatide has fewer side effects. The head-to-head SURMOUNT-5 trial gives us the best direct comparison data. For a full breakdown of these two medications beyond just side effects, see our detailed semaglutide vs tirzepatide comparison.

The pattern is consistent: tirzepatide generally has a more favorable GI side effect profile than semaglutide, with lower rates of nausea and vomiting across trials. This may be because tirzepatide's dual GIP/GLP-1 mechanism distributes its action across two receptor pathways. Interestingly, tirzepatide produces greater average weight loss while causing fewer GI side effects — a rare case where the more effective medication is also the better-tolerated one.

That said, individual responses vary enormously. Some patients tolerate semaglutide perfectly well but struggle with tirzepatide, and vice versa. If side effects are intolerable on one medication, switching to the other is a reasonable conversation to have with your provider. Both Wegovy and Zepbound are available through most major telehealth platforms.

How to Minimize Ozempic Side Effects: A Practical Checklist

Based on clinical evidence and patient experience, these are the most effective strategies for reducing side effects throughout your GLP-1 treatment. Think of this as your side-effect prevention playbook:

• •1. Never rush the titration — Follow the prescribed dose-escalation schedule. If side effects are rough at a particular dose, ask your provider about extending time at that level before moving up. There's no prize for reaching the maximum dose quickly.
• •2. Hydrate aggressively — Aim for at least 64-80 oz of water daily. Dehydration magnifies virtually every GLP-1 side effect — nausea, constipation, headache, fatigue, and kidney risk. Keep a water bottle with you at all times.
• •3. Restructure your meals — Shift to 5-6 small meals instead of 2-3 large ones. Prioritize lean protein (chicken, fish, Greek yogurt, eggs) at every meal. Minimize fried, greasy, and very spicy foods, especially during dose escalation.
• •4. Get 150 minutes of moderate exercise per week — Walking counts. Exercise improves GI motility (helping constipation), preserves lean muscle mass, enhances mood, and may reduce nausea. Resistance training is particularly important to counteract muscle loss.
• •5. Supplement strategically — A daily multivitamin (you're eating less food, so you need to cover nutrient gaps), protein supplement if needed (whey, collagen, or plant-based), magnesium citrate for constipation, and ginger for nausea.
• •6. Track your symptoms — Keep a simple log of what you eat, when you inject, and how you feel. Patterns will emerge. Many patients discover specific food triggers (e.g., dairy, large meals, alcohol) that they can then avoid.
• •7. Limit alcohol — Alcohol on an already-slow stomach can intensify nausea and increase pancreatitis risk. Many GLP-1 patients find their alcohol tolerance drops significantly. Start with much less than your usual amount.
• •8. Communicate with your provider — Don't suffer in silence. Good telehealth providers will adjust your titration schedule, prescribe anti-nausea medications, or switch you to a different GLP-1 if side effects are significantly impacting your quality of life.

If you're still in the research phase and haven't started treatment yet, our GLP-1 quiz can help you understand which medication and provider might be the best fit based on your health profile, budget, and preferences.

When to Call Your Doctor: Red Flag Symptoms

Most GLP-1 side effects are manageable at home. But certain symptoms require prompt medical attention. Contact your prescribing provider or seek emergency care if you experience any of the following:

• •Severe abdominal pain that is sharp, persistent, and doesn't improve — especially if it radiates to your back (possible pancreatitis) or is localized to the upper right abdomen (possible gallbladder issue)
• •Inability to keep liquids down for more than 24 hours due to vomiting — dehydration can escalate quickly and lead to kidney injury
• •Signs of an allergic reaction — swelling of the face, lips, tongue, or throat; difficulty breathing; severe rash or hives. This is rare but requires immediate emergency care
• •A lump or swelling in your neck, persistent hoarseness, or trouble swallowing — these could indicate thyroid changes that need evaluation
• •Dark, tea-colored urine or significantly decreased urination — potential signs of kidney stress from dehydration
• •Symptoms of hypoglycemia — severe shakiness, confusion, loss of consciousness — particularly if you take insulin or sulfonylureas alongside your GLP-1 medication
• •Blood in vomit or stool — this always warrants immediate medical evaluation regardless of cause
• •Severe, unrelenting diarrhea lasting more than 3 days, especially with fever
• •Vision changes — blurred vision or vision changes, particularly in diabetic patients, should be reported (diabetic retinopathy progression has been noted in some trials)

The Bottom Line on GLP-1 Side Effects

GLP-1 side effects are a trade-off — and for most patients, the clinical data strongly suggests the benefits outweigh the temporary discomfort. The STEP trials and SURMOUNT trials enrolled thousands of patients, and discontinuation rates due to adverse events were consistently in the single digits. The vast majority of patients who start GLP-1 therapy are able to continue it.

The patients who fare best are the ones who go in prepared: they understand what to expect, they follow the titration schedule, they stay hydrated, they restructure their eating habits, and they communicate openly with their providers. Side effects don't mean the medication isn't working — in many cases, they're a sign that your body is actively adjusting to a powerful new metabolic signal.

If you're comparing providers to start GLP-1 treatment, check our provider rankings to find a platform that offers strong clinical support — because having a responsive medical team makes a real difference when you're navigating side effects. You can also use our cost calculator to compare pricing across the major telehealth platforms.

For a deep dive into how the two main GLP-1 medications compare across all dimensions — including cost, efficacy, availability, and side effects — read our full semaglutide vs tirzepatide comparison.

Sources

• •STEP 1 Trial: Once-Weekly Semaglutide in Adults with Overweight or Obesity — Wilding et al., New England Journal of Medicine, 2021
• •SURMOUNT-1 Trial: Tirzepatide Once Weekly for the Treatment of Obesity — Jastreboff et al., New England Journal of Medicine, 2022
• •SURMOUNT-5 Trial: Tirzepatide vs Semaglutide for Obesity — Rodriguez et al., New England Journal of Medicine, 2024
• •Wegovy (semaglutide) Prescribing Information — FDA/Novo Nordisk, updated 2025
• •Zepbound (tirzepatide) Prescribing Information — FDA/Eli Lilly, 2023
• •Ginger for Nausea and Vomiting: An Updated Systematic Review and Meta-Analysis — Lete & Allue, Integrative Medicine Insights, 2016
• •SELECT Trial: Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes — Lincoff et al., New England Journal of Medicine, 2023